Project Grant HT94252310924
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This Project Grant award, valued at $159,341 and awarded on September 30, 2024, is funded through the Military Medical Research and Development program (CFDA 12.420) of the U.S. Department of the Army Medical Command. The grant supports research at The University of Texas Southwestern Medical Center in Dallas, Texas to target the PARP1 protein as a means of overcoming castration resistance in prostate cancer. The research aims to advance new treatment approaches for this condition, which is a...
The University of Texas Southwestern Medical Center was awarded a $1,467,321 project grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research from August 1, 2023 to July 31, 2026 to investigate the mechanisms controlling the progression of prostate adenocarcinoma to neuroendocrine cancer. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health Agency...
The University of Texas Southwestern Medical Center was awarded a $1,230,000 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to cotarget the trinity of DNA damage repair sensing kinases in prostate cancer from September 30, 2021 to September 29, 2024. Through this funding, the Medical Center will investigate medical solutions for prostate cancer by exploring inhibition of the ataxia telangiectasia...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
The University of Texas Southwestern Medical Center was awarded a $984,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Ribosome Marylation and Stress Responses in Ovarian Cancer: New Therapeutic Opportunities". The 3-year grant, effective September 1, 2024, will support basic science, translational, and clinical research to investigate new treatment approaches for ovarian cancer. As a...
The University of Texas at Dallas was awarded a $156,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 1, 2023 to February 28, 2025 to develop noninvasive diagnostic imaging techniques for aberrant sarcosine biochemistry in prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The Defense Health Agency awarded a $1.1 million project grant to the University of Texas Southwestern Medical Center in Dallas, Texas, to support research under the Military Medical Research and Development program. The three-year award beginning in June 2023 will fund the development of a multifunctional immunotherapy nanoparticle to enable innate immunotherapy for kidney cancer. As the prime awardee, UT Southwestern will leverage its expertise in oncology and immunology to advance this...
The University of Texas MD Anderson Cancer Center will receive $1,066,238 under a three-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 2022 to September 2025 to develop an integrated genomic and therapeutic strategy for androgen-indifferent prostate cancers. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $324,452 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant, titled "Targeting PARP1 Trapping to Overcome PARP Inhibitor Resistance for BRCAmut Ovarian Cancers," will support research aimed at developing new treatments for ovarian cancer in military populations. The funding will enable UT Southwestern, a leading academic...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $766,965 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on June 30, 2024. The grant supports a 3-year research project to develop new methods for targeting kidney cancer tumors in order to improve immunotherapy outcomes. The research aims to identify tumor surface biomarkers that can be leveraged to enhance the effectiveness of cancer...